unknown
Stage
1
Investors
About
Gauss Surgical develops an FDA-cleared medical device and software platform (Triton) that uses computer vision and AI to measure perioperative blood loss by analyzing images of surgical sponges and suction canisters, providing clinicians with real-time quantitative blood loss estimates.
Explore Gauss Surgical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.